Qualigen Therapeutics, Inc. 10-K Cybersecurity GRC - 2024-04-05

Page last updated on April 11, 2024

Qualigen Therapeutics, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-05 21:59:24 EDT.

Filings

10-K filed on 2024-04-05

Qualigen Therapeutics, Inc. filed an 10-K at 2024-04-05 21:59:24 EDT
Accession Number: 0001493152-24-013400

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity Our processes for assessing, identifying, and managing material risks from cybersecurity threats are not advanced. None of our personnel are trained specialists in cybersecurity we rely on off-the-shelf security software. We have not conducted employee training regarding cybersecurity or conducted internal tests or simulations. Nonetheless, we believe that, due to the nature and status of our business, our cybersecurity position is currently satisfactory for our situation. We do not believe that cybersecurity risks have materially affected (or are reasonably likely to materially affect) us. We have only four employees and so disclosure of cybersecurity events to management would occur organically, or would in the first instance be observed by management. For information of ours which resides on our CROs computer systems, we rely on the CROs own cybersecurity processes and systems.

Company Information